Ultrasound-guided sclerotherapy with 76% meglumine diatrizoate for bilateral chylothorax after thyroid cancer surgery: a case report.
증례보고
1/5 보강
Bilateral chylothorax following thyroid cancer surgery is exceedingly rare, and management becomes more challenging when one side presents as high-output (>1,000 mL/day).
APA
Luo Q, Peng Y, et al. (2025). Ultrasound-guided sclerotherapy with 76% meglumine diatrizoate for bilateral chylothorax after thyroid cancer surgery: a case report.. Frontiers in oncology, 15, 1684418. https://doi.org/10.3389/fonc.2025.1684418
MLA
Luo Q, et al.. "Ultrasound-guided sclerotherapy with 76% meglumine diatrizoate for bilateral chylothorax after thyroid cancer surgery: a case report.." Frontiers in oncology, vol. 15, 2025, pp. 1684418.
PMID
41573650
Abstract
Bilateral chylothorax following thyroid cancer surgery is exceedingly rare, and management becomes more challenging when one side presents as high-output (>1,000 mL/day). Conservative treatments often yield limited success. We report a case of recurrent papillary thyroid carcinoma in which bilateral chylothorax was diagnosed on postoperative day (POD) 5 by chest radiography and qualitative chyle tests, with right-sided drainage exceeding 1,000 mL/day. After 19 days of ineffective conservative therapy, 76% meglumine diatrizoate was percutaneously injected into the lymphatic leak site under ultrasound guidance, followed by external compression. The drainage volume decreased significantly and fully resolved within 10 days, without systemic adverse effects. To our knowledge, this is the first report of successful treatment of bilateral chylothorax after thyroidectomy using this approach. The findings suggest that local sclerotherapy with meglumine diatrizoate offers a minimally invasive, safe, and technically simple alternative, particularly for patients who fail conservative therapy but are not suitable surgical candidates.
같은 제1저자의 인용 많은 논문 (5)
- Contrast-enhanced CT-based radiomics for predicting visceral pleural invasion in early-stage non-small cell lung cancer.
- Age-Based Left-Digit Bias in the Treatment of Pancreatic Adenocarcinoma.
- Associations of serum lipid traits with DLBCL: a prospective cohort study from the UK Biobank.
- NCAPD2 Modulates MHC-I Antigen Presentation via the PI3K/AKT Axis to Drive Metastatic Progression in Gastric Cancer.
- Development and external validation of interpretable machine learning models for personalized multiple treatment recommendations in non-small cell lung cancer.